Ritleng®+ Autostable Ritleng® Intubation
Ritleng®+ is FCI’s latest autostable bicanalicular nasolacrimal intubation indicated for epiphora, canalicular pathologies, congenital lacrimal duct obstruction, and dacryocystorhinostomy (DCR).
Ritleng®+ consists of a silicone tube connected at each extremity to a black Polyetheretherketone PEEK thread guide. It is designed to reduce operating time and trauma for the patients in the intubation phase as well as with the removal of the device. The intubation is self-retaining because of two wider silicone portions on the silicone tube.
The surgical procedure is similar to the conventional Ritleng® lacrimal intubation and involves the use of Ritleng® instruments. Ritleng®+ combines the best features of gold standard Ritleng® lacrimal intubation set and the auto-stable features of FCI Nunchaku.
Main characteristics :
• Indicated for the treatment of epiphora, canalicular pathologies, congenital nasolacrimal
duct obstruction and dacryocystorhinostomy (DCR) in patients age 12 months and older
• Standard 0.64 mm silicone tube for a comfortable fit in the interpalpebral space
• Wider 0.94 mm silicone segments positioned in the lacrimal sac ensuring the self-retaining
feature of the intubation: no need for knots or sutures
• Black mark to control the central placement and correct positioning of the silicone tube
between the two puncta
• PEEK length: 500 mm
• Easy nasal retrieval